Sanofi and Regeneron Pharmaceuticals Inc. are moving swiftly to start trials to see whether their rheumatoid arthritis drug Kevzara could treat the symptoms of coronavirus.
The French drug-maker told Scrip that "there is scientific rationale that supports the exploration" of Kevzara (sarilumab), its interleukin-6 (IL-6)...






